Autonomix Medical, Inc.
AMIX
$1.07
$0.010.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 182.66% | 14.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 120.23% | 5.20% | |||
| Operating Income | -120.23% | -5.20% | |||
| Income Before Tax | -123.28% | -4.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -123.28% | -4.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -123.28% | -4.58% | |||
| EBIT | -120.23% | -5.20% | |||
| EBITDA | -120.36% | -6.68% | |||
| EPS Basic | -28.11% | 7.32% | |||
| Normalized Basic EPS | -28.11% | 7.33% | |||
| EPS Diluted | -28.11% | 7.32% | |||
| Normalized Diluted EPS | -28.11% | 7.33% | |||
| Average Basic Shares Outstanding | 74.28% | 12.84% | |||
| Average Diluted Shares Outstanding | 74.28% | 12.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||